Print

Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for half year ended September 30, 2007
(Rs.Lakhs)
   
Standalone Results
Consolidated Results
S.No
Particulars
Three months ended
30-Sep-07
(Unaudited)
Three months ended
30-Sep-06
(Unaudited)
Six months ended 30-Sep-07 (Unaudited)
 Six months ended 30-Sep-06 (Unaudited) Year ended 31-Mar-07 (Audited)
Six months ended 30-Sep-07 (Unaudited)
Six months ended 30-Sep-06 (Unaudited)
Year ended 31-Mar-07 (Audited)
1
 Sales and Operating Income
29,512.98
24,573.13
53,332.62
44,744.11
93,417.55
56,109.55
47,282.68
98,508.07
2
 Other Income
30.50
22.06
60.59
100.19
155.98
0.39
125.33
35.62
3
 Total Income
29,543.48
24,595.19
53,393.21
44,844.30
93,573.53
56,109.94
47,408.01
98,543.69
4
 Expenditure
a) Decrease/(Increase) in Stock in trade
(4,870.53)
(6,052.77)
(8,061.50)
(9,401.71)
(14,012.10)
(8,493.60)
(9,344.06)
(13,745.93)
b) Material cost
11,805.32
13,302.27
21,598.33
24,041.28
42,899.90
24,028.25
25,238.59
47,675.36
c) Purchase of Traded Goods
1,094.65
592.55
1,434.28
932.18
2,167.75
1,434.28
932.18
1,434.28
  d) Staff Cost
2,388.50
2,092.55
4,615.98
3,810.22
7,772.57
5,375.06
3,884.81
9,244.64
  e) Depreciation / Amortisation
2,232.46
2,009.30
4,531.22
3,941.68
8,246.73
4,650.37
4,074.42
8,508.92
f) Other Expenditure
8,725.47
6,910.14
16,784.76
11,538.90
26,360.09
17,088.26
13,468.18
26,992.84
  g) Total
21,375.87
18,854.04
40,903.07
34,862.55
73,434.94
44,082.62
38,254.12
80,110.11
5
Profit from Ordinary Activities before Interest & Exceptional item (3-4)
8,167.61
5,741.15
12,490.14
9,981.75
20,138.59
12,027.32
9,153.89
18,433.58
6
 Interest and Finance Charges
1,715.42
2,559.29
3,733.27
4,762.15
9,830.65
3,782.26
4,814.10
9,929.15
7
 Profit from Ordinary Activities before Exceptional Item (5-6)
6,452.19
3,181.86
8,756.87
5,219.60
10,307.94
8,245.06
4,339.79
8,504.43
8
 Exceptional Item
1,975.80
53.22
7,261.98
(240.46)
751.24
7,261.98
(240.46)
751.24
9
 Profit before Tax after Exceptional Item (7+8)
8,427.99
3,235.08
16,018.85
4,979.14
11,059.18
15,507.04
4,099.33
9,255.67
10
 Tax Expenses
    - Current Tax & Deferred Tax
2,074.73
250.00
4,494.78
500.00
1,230.00
4,494.78
500.00
1,230.00
    - Fringe Benefit Tax
26.00
40.00
67.00
75.00
166.00
67.00
75.00
170.78
11
 Net Profit After Tax (9-10)
6,327.26
2,945.08
11,457.07
4,404.14
9,663.18
10,945.26
3,524.33
7,854.89
12
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
6,582.80
6,581.17
6,582.80
6,581.17
6,581.63
6,582.80
6,581.17
6,581.63
13
 Reserves excluding Revaluation Reserves
-
-
-
-
43,542.57
-
-
41,928.64
14
 Basic Earnings per Share (EPS) Rs.*
9.61*
4.48*
17.41*
6.70*
14.70
16.63*
5.36*
11.96
15
 Diluted Earnings per Share (EPS) Rs.*
6.46*
4.01*
11.69*
5.99*
13.23
11.17*
4.79*
10.76
16
 Aggregate of Public Shareholding
  - Number of equity shares
50218854
54020568
50218854
54020568
50833619
  -Percentage of Shareholding
76.29
82.09
76.29
82.09
77.24
* EPS is for the period (not annualised)
  • The Company is operating in single segment (i.e) "Pharmaceuticals".
  • In accordance with the revised AS 15, necessary provision has been made for the employee benefits during the period. The increase in liability as at the commencement of the year as per revised AS 15 will be adjusted against the opening reserves in accordance with the said standard.
  • Exceptional item represents exchange gain on outstanding Foreign Currency Convertible Bonds. Tax expenses include tax on Exceptional item
    of Rs. 845.37 lakhs for the quarter ended September 30, 2007 and Rs. 2784.30 lakhs for the half year ended September 30, 2007.
  • The Allotment Committee of the Board has allotted shares as follows:
    - 5650 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on July 17, 2007.
    - 6000 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on October 18, 2007.
  • The Company received 16 complaints during the quarter ended September 30, 2007 from the shareholders. All the complaints have been resolved and no complaints were pending as on September 30, 2007.
  • The above financial results were taken on record by the Board of Directors at its meeting held on Thursday, October 18, 2007.
  • The standalone accounts have been subjected to limited review by the Statutory Auditors.
  • Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : October 18, 2007

For and on behalf of the Board

K.Raghavendra Rao
Managing Director